Buy Flunitrazolam 0.25 mg Pellets – Premium Research Chemical | euro-labchems.com

Flunitrazolam 0.25 mg Pellets CAS Number: 207740-33-8 Molecular Formula: C₁₇H₁₂F₂N₄S Molecular Weight: 358.37 g/mol Purity: ≥98.5% (HPLC verified) Dosage per pellet: Exactly 0.25 mg Flunitrazolam Form: Compressed pharmaceutical-grade pellets (uniform, scored for precision) Quantity options: 10, 20, 50, 100, 200 pellets Shipping: Discreet worldwide, vacuum-sealed, moisture-proof packaging

euro-labchems.com supplies laboratory-verified Flunitrazolam 0.25 mg pellets – one of the most potent thienotriazolodiazepine research chemicals ever documented. A fluorinated analog of flunitrazepam (Rohypnol) and etizolam, Flunitrazolam is a high-affinity GABA-A receptor positive allosteric modulator (primarily α1, α2, α3 subunits), producing extremely strong classical benzodiazepine effects.

What is Flunitrazolam?

Flunitrazolam is a designer benzodiazepine characterized by dual fluorine substitutions, resulting in dramatically increased potency (estimated 10–20× etizolam, 40–80× alprazolam in some reports). The 0.25 mg pellet is a microdose/standard research dose for studying ultra-potent GABAergic ligands, receptor binding, metabolism, toxicology, and behavioral pharmacology.

Key Product Specifications of Flunitrazolam 0.25 mg Pellets

• Pellet size: Small, consistent 3–4 mm diameter
• Excipients: Inert binders for stability & accurate dosing
• Stability: Excellent cool/dark/dry storage (2+ years)
• Potency: 0.25 mg per pellet – microdose/standard research dose (analog potency range: 0.1–0.5 mg common)

Research Effects & Characteristics

Duration: 8–16 hours Onset: 20–60 minutes Peak: 2–6 hours

Preclinical and analog literature indicate exceptionally potent benzodiazepine effects: profound sedation, rapid anxiolysis, heavy muscle relaxation, strong anticonvulsant activity, profound amnesia, and deep hypnosis. Frequently described as one of the strongest and longest-acting designer benzodiazepines, with very rapid onset and extremely flat dose-response curve at research doses.

Possible side effects (dose-dependent, research observations): severe sedation, respiratory depression risk, ataxia, profound cognitive impairment, strong rebound anxiety, very high tolerance/dependence potential, rare paradoxical agitation.

Flunitrazolam are sold strictly for scientific research – not for human/veterinary consumption. Verify local regulations. Full CoA available.

Premium Flunitrazolam pellets for precise benzodiazepine receptor research from euro-labchems.com – your trusted specialist.